StockpollyBeta
Get App
Popularity #1,624
BNTX · NASDAQ · Biotechnology

BioNTech (ADR) (BNTX)

Develops oncology medicines while commercializing the Pfizer-partnered Comirnaty vaccine.

$101.99
After hours+1.19 (+1.18%)
At close$100.80(+2.86%)

In millions of USD, except per-share figures · converted from EUR at the latest rate

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue1,0251,6942151471,4251,3632092991,7391,029137121
Cost of revenue18520568682052799687170378224111
Gross profit8401,488147791,2211,0841132111,569651−8710
7568867281,1851,2099147257851,6239156831,095
Research & development570662581669630701602583647573648631
176171152210172151138157170334173226
Selling & marketing162118152124162331563246
General & administrative159150134196152127122135139278141181
Other expenses1053−530540662−15458068−138238
Operating income84603−581−1,10612170−612−574−54−264−769−1,086
177157201184170175102113826108102
Interest income1851752081930000029872111
Interest expense2225860740759
Other non-operating income−179171−206−188−179−172−140−117−82−13−113−111
Income before tax260759−380−923182345−510−46128−258−661−983
Income tax expense76235−192−4548−34−186188−42−43
Net income from continuing operations184524−361−925227297−476−443−33−346−619−940
Net income184524−361−925227297−476−443−33−346−619−940
EPS, basic$0.79$2.15−$1.50−$3.92$0.95$1.24−$1.98−$1.83−$0.14−$1.41−$2.45−$3.71
EPS, diluted$0.79$2.11−$1.50−$3.92$0.93$1.24−$1.98−$1.83−$0.14−$1.41−$2.45−$3.71
Weighted average shares, basic240238241238240240240242239245253253
Weighted average shares, diluted240241241238245240240242239245253253
EBITDA310522−331−862242532−422−399171−64−515−670
Depreciation & amortization47904457511894958142187141305
EBIT263431−375−919191342−471−45729−251−657−974